Catequentinib hydrochloride: all 93 studies that test it
Page 1 of 1. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.
- Anlotinib + Benmelstobart vs Surgery for Patients With Localized Renal Cell Carcinoma Scheduled to Undergo Partial NephrectomyNot yet recruitingNCT07627464Phase 2
- Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal CarcinomaNot yet recruitingNCT07385079Phase 3
- A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung CancerRecruitingNCT07358676Phase 2
- SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung CancerRecruitingNCT06476093Not applicable
- Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial CancerNot yet recruitingNCT06475599Phase 3
- Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLCRecruitingNCT06379087Phase 2
- A-RGEMOX in the Treatment of Early Relapsed/Refractory DLBCLRecruitingNCT06086197Phase 2
- Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid CancerNot yet recruitingNCT06062563Not applicable
- A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.RecruitingNCT06010901Phase 1
- Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal CarcinomaNot yet recruitingNCT05996484Phase 2
- A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and ChemotherapyRecruitingNCT05942508Phase 1
- A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung CancerRecruitingNCT05913089Phase 2
- Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.RecruitingNCT05862337Phase 3
- Study of Anlotinib in Patients With Advanced Medullary Thyroid CarcinomaRecruitingNCT05830500Phase 4
- TQB2450 Injection Combined With Chemotherapy Followed by Sequential Combination With Anlotinib Hydrochloride Capsule for First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer.Not yet recruitingNCT05718167Phase 3
- Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable MelanomaNot yet recruitingNCT05539118Phase 1/2
- XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction AdenocarcinomaRecruitingNCT05494060Phase 2
- Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma PatientsRecruitingNCT05252078Phase 2
- Preoperative IMRT With Anlotinib and Penpulimab for Localized Sarcoma （SPARE-01）RecruitingNCT05167994Phase 2
- Anlotinib Hydrochloride Combined With AP in Stage IIIB/IIIC/IV Non-squamous Non-small-cell Lung CancerCompletedNCT04012619Phase 1Results posted
- Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung CancerTerminatedNCT06897579Phase 2
- Neoadjuvant Therapy for Locally Advanced Rectal CancerActive, not recruitingNCT06853769Early Phase 1
- A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC).TerminatedNCT05975645Phase 1
- A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGLStatus unknownNCT05883085Phase 2
- Pharmacokinetic Study of Anlotinib Hydrochloride Capsules in Healthy Subjects and Liver Dysfunction PatientsStatus unknownNCT05559242Phase 1
- Anlotinib Hydrochloride Capsule Monotherapy and Combination Therapy Relapsed and Refractory Multiple MyelomaStatus unknownNCT05549973Phase 1
- Anlotinib , Penpulimab Combined With SBRT for Metastatic Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT05485350Phase 2
- Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.TerminatedNCT05481645Phase 2
- AK105 Plus Anlotinib Hydrochloride Combined With Albumin Paclitaxel as a First-line Therapy in Patients With Advanced Triple-negative Breast CancerStatus unknownNCT05244993Phase 2
- Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal CarcinomaStatus unknownNCT05232552Phase 2
- A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian CancerStatus unknownNCT05145218Phase 3
- Anlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell CarcinomaStatus unknownNCT05124431Phase 2
- A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial CarcinomaStatus unknownNCT05121363Phase 2
- TQB2450 Plus Anlotinib as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After ResectionStatus unknownNCT05111366Phase 2
- A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOxStatus unknownNCT05068206Phase 2
- Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal CancerStatus unknownNCT05035914Phase 1/2
- Study on the Treatment of Differentiated Thyroid Carcinoma with AnlotinibActive, not recruitingNCT05007093Phase 2
- A Phase II Study of Sintilimab Combined With Anlotinib in Treatment of ED-SCLCStatus unknownNCT04967625Phase 2
- A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)Status unknownNCT04964479Phase 3
- Newly Diagnosed GlioblastomaActive, not recruitingNCT04959500Phase 2
- Anlotinib or Penpulimab in Combination With RAI for DTCStatus unknownNCT04952493Phase 2
- Adjuvant Therapy With Anlotinib for HCCWithdrawnNCT04947371Phase 2
- A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung CancerTerminatedNCT04924192Phase 2
- TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction AdenocarcinomaActive, not recruitingNCT04891900Not applicable
- The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or ParagangliomaCompletedNCT04860700Phase 2
- A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal CancerActive, not recruitingNCT04854668Phase 3
- A Study of Anlotinib Hydrochloride Capsules in Subjects With Diffuse Large B-Cell LymphomaStatus unknownNCT04827004Phase 2
- A Study of Anlotinib in the Treatment of Recurrent High-grade GliomaStatus unknownNCT04822805Phase 2
- A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subjects With Advanced Biliary CancerStatus unknownNCT04809142Phase 3
- A Study of Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal CarcinomaCompletedNCT04736810Phase 2
- Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung CancerStatus unknownNCT04684017Phase 2
- Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in ChildrenStatus unknownNCT04659733Phase 1
- Eribulin Combined With Anlotinib in Metastatic HER2 Negative Breast CancerStatus unknownNCT04624711Phase 2
- Tislelizumab in Combination With Anlotinib With ES-SCLC as Maintenance Therapy After First Line ChemotherapyStatus unknownNCT04620837Phase 2
- A Trial of Anlotinib Combined With Docetaxel in EGFR Mutations Advanced Non Small Cell Lung Cancer PatientsStatus unknownNCT04619563Phase 2
- A Trial of Anlotinib Combined With Docetaxel in Patients With Wild-type Advanced Non-squamous Non Small Cell Lung CancerStatus unknownNCT04619537Phase 2
- Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP RegimenStatus unknownNCT04547855Phase 2
- Treating Locally Advanced Head and Neck Malignant Tumor With Anlotinib and ChemoradiotherapyStatus unknownNCT04507035Phase 4
- Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal CancerStatus unknownNCT04503967Phase 2
- A Efficacy and Safety Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy as First-line Treatment in Subjects With Advanced Non-squamous Cell Non-small Cell Lung CancerStatus unknownNCT04439890Phase 3
- Osimertinib Combined With Anlotinib in EGFR T790M Mutated NSCLC Patients With Progression on Osimertinib TreatmentTerminatedNCT04438902Phase 2
- A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction AdenocarcinomaStatus unknownNCT04385550Phase 3
- First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLCStatus unknownNCT04363255Phase 2
- A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)Active, not recruitingNCT04344158Phase 3
- Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride CapsuleCompletedNCT04223583Phase 4
- Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery RecurrenceStatus unknownNCT04213118Phase 2
- Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung CancerStatus unknownNCT04192682Phase 2/3
- A Study of Neoadjuvant Chemotherapy Plus Anlotinib in Stage III(N2) Non-small-cell Lung CancerStatus unknownNCT04181372Phase 2
- A Study of the Combination of Anti-PD-1 AK105 and Anlotinib in First-line Hepatocellular Carcinoma (HCC)CompletedNCT04172571Phase 2
- Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed GlioblastomaStatus unknownNCT04157478Phase 2
- A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung CancerStatus unknownNCT04111913Phase 2
- Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC PatientsCompletedNCT04080843Phase 2
- TACE Combined With Anlotinib Treatment of Middle-advanced Hepatocellular Carcinoma (HCC) PatientsStatus unknownNCT04066543Phase 2
- Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）.Status unknownNCT04063683Phase 2
- Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic ChordomaStatus unknownNCT04042597Phase 2
- Gefitinib in Combination With Anlotinib or Placebo in Previously Untreated EGFR-mutant NSCLCStatus unknownNCT04028778Phase 3
- Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKIStatus unknownNCT04007835Not applicable
- Anlotinib in Metastatic HER2 Negative Breast CancerCompletedNCT04002284Phase 2
- Anlotinib Single Drug as the Maintenance Treatment for Advanced NSCLCStatus unknownNCT03998085Not applicable
- Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue SarcomaCompletedNCT03951571Phase 2
- A Multicenter Study of Anlotinib in Hepatocellular Carcinoma (HCC) Patients at High Risk of Post Surgery RecurrenceTerminatedNCT03945799Phase 1/2
- Anlotinib Maintenance Treatment for Advanced Soft Tissue SarcomaCompletedNCT03890068Phase 2
- Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib HydrochlorideStatus unknownNCT03890055Phase 4
- Study of Anlotinib as the Maintenance Therapy for Extensive-stage Small Cell Lung CancerStatus unknownNCT03781869Phase 2
- Efficacy and Safety of Anlotinib as Maintenance Treatment After First-line Chemotherapy in SCLCStatus unknownNCT03780283Phase 2
- Study of Anlotinib in Advanced Non-squamous NSCLC Patients in the Elderly Without Systemic Chemotherapy (ALTER-L006)Status unknownNCT03778853Phase 4
- Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung CancerStatus unknownNCT03766490Not applicable
- Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M NegativeStatus unknownNCT03765775Phase 2
- Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung CancerStatus unknownNCT03750916Phase 2
- Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer（ALTER-L034）Status unknownNCT03735264Phase 2
- Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLCStatus unknownNCT03703596Phase 2
- A Study of Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLCStatus unknownNCT03700359Phase 2
- Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal CancerStatus unknownNCT03545711Phase 1/2